News & Updates
Filter by Specialty:

Varenicline plus naltrexone may aid in smoking cessation, drinking reduction
Varenicline alone is an adequate therapy for smoking cessation in heavy-drinking smokers, but combining it with naltrexone may provide benefits in terms of drinking outcomes, particularly during the 12-week period of active medication treatment, suggests a study.
Varenicline plus naltrexone may aid in smoking cessation, drinking reduction
04 Oct 2021
Azathioprine shows promise in maintenance treatment of autoimmune pancreatitis
Treatment with azathioprine helps prevent relapse of autoimmune pancreatitis, according to the results of a systematic review and meta-analysis.
Azathioprine shows promise in maintenance treatment of autoimmune pancreatitis
04 Oct 2021
COVID-19 vacc side effects: Fewer than expected?
A community-based study from the UK showed that the rate of systemic side effects is relatively low following vaccination with the BNT162b2 or ChAdOx1 nCoV-19 COVID-19 vaccines.
COVID-19 vacc side effects: Fewer than expected?
01 Oct 2021
Pimavanserin for dementia-related psychosis: to continue or not?
In individuals with dementia-related psychosis (DRP) who had a response to the oral 5-HT2A* inverse agonist and antagonist pimavanserin, an atypical antipsychotic agent, the risk of relapse was lower among those who continued the drug vs those who stopped it, the phase III HARMONY trial suggests.